HCS
NEOS

Harvest Capital Strategies’s Neos Therapeutics, Inc NEOS Stock Holding History

Harvest Capital Strategies’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-219,317
Closed -$2.24M – 67
2017
Q4 		$2.24M Buy
+219,317
New +$2.1M 0.39% 47

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harvest Capital Strategies's NEOS Position: Q1 2018 in Review

Harvest Capital Strategies sold out of Neos Therapeutics, Inc (NEOS) in Q1 2018, closing a stake of 219,317 shares — an estimated $2.24M sold.

Harvest Capital Strategies first reported a position in NEOS in Q4 2017 and held it in 1 quarter. The position peaked at $2.24M in Q4 2017. 77 funds tracked by Wall St. Rank hold NEOS as of Q1 2018.

  • Harvest Capital Strategies reported no remaining Neos Therapeutics, Inc position as of Q1 2018 after selling out during the quarter.
  • Harvest Capital Strategies sold 219,317 Neos Therapeutics, Inc shares in Q1 2018, an estimated $2.24M.
  • Harvest Capital Strategies first reported a position in Neos Therapeutics, Inc in Q4 2017 and held it in 1 quarter.
  • Harvest Capital Strategies's Neos Therapeutics, Inc position peaked at $2.24M in Q4 2017.
  • 77 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2018.

Based on Harvest Capital Strategies's 13F filing for Q1 2018, filed 15 May 2018.